Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Apoptosis Proteins and Complement Components in the Etiopathogenesis of Systemic Lupus Erythematosus
Bernadete L. Liphaus, Maria Helena Bittencourt Kiss
Clinics (2010) Vol. 65, Iss. 3, pp. 327-333
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Systemic lupus erythematosus
Arvind Kaul, Caroline Gordon, Mary K. Crow, et al.
Nature Reviews Disease Primers (2016) Vol. 2, Iss. 1
Closed Access | Times Cited: 1089
Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus
Nasim Bolouri, Maryam Akhtari, Elham Farhadi, et al.
Inflammation Research (2022) Vol. 71, Iss. 5-6, pp. 537-554
Closed Access | Times Cited: 42
Systemic Lupus Erythematosus Features in Elderly Patients: Case-Based Review
Alexandr Ceasovschih, Raluca-Elena Alexa, Victorița Şorodoc, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 8, pp. 2558-2558
Open Access
Expression of autophagy related genes mTOR, Becline-1, LC3 and p62 in the peripheral blood mononuclear cells of systemic lupus erythematosus.
Zhenzhen Wu, Junjun Zhang, Congcong Gao, et al.
PubMed (2017) Vol. 6, Iss. 1, pp. 1-8
Closed Access | Times Cited: 43
Jak Inhibitors for Treatment of Autoimmune Diseases: Lessons from Systemic Sclerosis and Systemic Lupus Erythematosus
Przemysław Kotyla, Olga Gumkowska-Sroka, Bartosz Wnuk, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 936-936
Open Access | Times Cited: 18
Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis
Maria Wigren, Elisabet Svenungsson, Ingrid Yao Mattisson, et al.
Atherosclerosis (2018) Vol. 270, pp. 1-7
Closed Access | Times Cited: 31
Association between the Presence of Autoantibodies Targeting Ficolin-3 and Active Nephritis in Patients with Systemic Lupus Erythematosus
Maëlle Plawecki, Elise Lheritier, Giovanna Clavarino, et al.
PLoS ONE (2016) Vol. 11, Iss. 9, pp. e0160879-e0160879
Open Access | Times Cited: 29
Association of FAS and FAS Ligand Genes Polymorphism and Risk of Systemic Lupus Erythematosus
Bita Moudi, Saeedeh Salimi, Farzaneh Farajian‐Mashhadi, et al.
The Scientific World JOURNAL (2013) Vol. 2013, Iss. 1
Open Access | Times Cited: 29
Safety and pharmacodynamics of venetoclax (ABT-199) in a randomized single and multiple ascending dose study in women with systemic lupus erythematosus
Peng Lü, Roy Fleischmann, C. Martin Curtis, et al.
Lupus (2017) Vol. 27, Iss. 2, pp. 290-302
Closed Access | Times Cited: 28
CAR T cell therapy for refractory pediatric systemic lupus erythematosus: a new era of hope?
Ivana Stojkic, Lauren Harper, Samantha Coss, et al.
Pediatric Rheumatology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Association of Fas gene polymorphisms with systemic lupus erythematosus: a meta-analysis
Nan Xiang, Xiaomei Li, Guosheng Wang, et al.
Molecular Biology Reports (2012) Vol. 40, Iss. 1, pp. 407-415
Closed Access | Times Cited: 27
Apoptosis in immune-mediated diseases
S. Sankari, N. Aravindha Babu, E Rajesh, et al.
Journal of Pharmacy And Bioallied Sciences (2015) Vol. 7, Iss. 5, pp. 200-200
Open Access | Times Cited: 24
IL-1βand IL-6 Are Highly Expressed in RF+IgE+ Systemic Lupus Erythematous Subtype
Yongkang Wu, Bei Cai, Jun-Long Zhang, et al.
Journal of Immunology Research (2017) Vol. 2017, pp. 1-8
Open Access | Times Cited: 22
Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
Fabien B. Vincent, Rangi Kandane‐Rathnayake, Rachel Koelmeyer, et al.
Lupus Science & Medicine (2020) Vol. 7, Iss. 1, pp. e000375-e000375
Open Access | Times Cited: 18
Increased serum sFas, sTRAIL, and reduced sFasL in juvenile-onset systemic lupus erythematosus
Bernadete L. Liphaus, Mária Kiss, Solange Carrasco, et al.
Clinical Rheumatology (2017) Vol. 36, Iss. 12, pp. 2847-2852
Closed Access | Times Cited: 16
Investigation of the caspase-dependent mitochondrial apoptotic pathway in mononuclear cells of patients with systemic lupus erythematosus
Yu‐Jih Su, Tien‐Tsai Cheng, Chung‐Jen Chen, et al.
Journal of Translational Medicine (2014) Vol. 12, Iss. 1
Open Access | Times Cited: 15
Evaluation of polymorphic variants in apoptotic genes and their role in susceptibility and clinical progression to systemic lupus erythematosus
Nadine Glesse, Priscila Vianna, Lia Mara Gomes Paim, et al.
Lupus (2016) Vol. 26, Iss. 7, pp. 746-755
Closed Access | Times Cited: 14
High ACSL5 Transcript Levels Associate with Systemic Lupus Erythematosus and Apoptosis in Jurkat T Lymphocytes and Peripheral Blood Cells
Antonio Catalá-Rabasa, Dorothy Ndagire, José Mario Sabio, et al.
PLoS ONE (2011) Vol. 6, Iss. 12, pp. e28591-e28591
Open Access | Times Cited: 15
Increased IgE serum levels are unrelated to allergic and parasitic diseases in patients with juvenile systemic lupus erythematosus
Bernadete L. Liphaus, Adriana A. de Jesus, Clóvis A. Silva, et al.
Clinics (2012) Vol. 67, Iss. 11, pp. 1275-1280
Open Access | Times Cited: 15
Reduced expressions of apoptosis-related proteins TRAIL, Bcl-2, and TNFR1 in NK cells of juvenile-onset systemic lupus erythematosus patients: relations with disease activity, nephritis, and neuropsychiatric involvement
Bernadete L. Liphaus, Simone C. Silva, Patrícia Palmeira, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Molecular characterization of the complement C1q, C2 and C4 genes in Brazilian patients with juvenile systemic lupus erythematosus
Bernadete L. Liphaus, Natalia Umetsu, Adriana A. de Jesus, et al.
Clinics (2015) Vol. 70, Iss. 3, pp. 220-227
Open Access | Times Cited: 11
Increased glomerular Bax/Bcl2 ratio is positively correlated with glomerular sclerosis in lupus nephritis
Ghada Hosny, Wesam Ismail, Rania Makboul, et al.
Pathophysiology (2018) Vol. 25, Iss. 2, pp. 83-88
Closed Access | Times Cited: 7
Exposure-Response Analyses of the Effects of Venetoclax, a Selective BCL-2 Inhibitor, on B-Lymphocyte and Total Lymphocyte Counts in Women with Systemic Lupus Erythematosus
Ahmed Nader, Mukul Minocha, Mohamed I. A. Othman
Clinical Pharmacokinetics (2019) Vol. 59, Iss. 3, pp. 335-347
Closed Access | Times Cited: 6
Increased sMer, but not sAxl, sTyro3, and Gas6 relate with active disease in juvenile systemic lupus erythematosus
Bernadete L. Liphaus, Laila Lima, Patrícia Palmeira, et al.
Clinical Rheumatology (2019) Vol. 39, Iss. 2, pp. 509-514
Closed Access | Times Cited: 5
Association of BCL2 polymorphisms and the IL19 single nucleotide polymorphism rs2243188 with systemic lupus erythematosus
Weijie Wang, Xinchang Wang, Kepeng Yang, et al.
Journal of International Medical Research (2021) Vol. 49, Iss. 5
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top